Literature DB >> 20518197

Erectile dysfunction in aging male.

Francesco Romanelli1, Andrea Sansone, Andrea Lenzi.   

Abstract

With the increasing longevity in men and women, sexual health concerns have become more and more important and demands for help are far more common than in the past. Erectile dysfunction's severity and prevalence both increase with aging: since erectile dysfunction is a symptom, physicians should diagnose underlying pathologies that might lead to it instead of focusing on finding a viable treatment. Cardiovascular alterations occur in the elderly, and might lead to erectile dysfunction because of penile blood flow impairment: diabetes, smoking, and sedentary life-style, being risk factors for vascular pathologies, can affect erectile function. Metabolic syndrome and psychological factors are highly prevalent in aging men, and might be other important determinants of erectile dysfunction. Drugs play a role in the pathogenesis of erectile dysfunction, as they can alter hormonal or vascular mechanics needed for achieving or maintaining erection. Alterations in penile vessels can be observed in the elderly: lack of androgens might lead to a reduction of smooth muscle cells content in the penis and an increase in the caliber of vascular spaces. Hypogonadism, when present, should be treated regardless of age; furthermore, synergistic effects have been found during testosterone replacement therapy when using an oral therapy with a PDE-5 inhibitor (sildenafil, vardenafil or tadalafil). These therapies are effective in the elderly, with no increase in the frequency of adverse events, and might also help in providing relief from lower urinary tract symptoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518197

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


  9 in total

Review 1.  Hormonal correlations of premature ejaculation.

Authors:  Andrea Sansone; Francesco Romanelli; Emmanuele A Jannini; Andrea Lenzi
Journal:  Endocrine       Date:  2015-01-01       Impact factor: 3.633

Review 2.  Endocrine evaluation of erectile dysfunction.

Authors:  Andrea Sansone; Francesco Romanelli; Daniele Gianfrilli; Andrea Lenzi
Journal:  Endocrine       Date:  2014-04-06       Impact factor: 3.633

3.  "Mask up to keep it up": Preliminary evidence of the association between erectile dysfunction and COVID-19.

Authors:  Andrea Sansone; Daniele Mollaioli; Giacomo Ciocca; Elena Colonnello; Erika Limoncin; Giancarlo Balercia; Emmanuele A Jannini
Journal:  Andrology       Date:  2021-03-30       Impact factor: 4.456

4.  Testosterone and vascular function in aging.

Authors:  Rhéure A M Lopes; Karla B Neves; Fernando S Carneiro; Rita C Tostes
Journal:  Front Physiol       Date:  2012-04-10       Impact factor: 4.566

5.  Diagnostic value of four-dimensional CT angiography in arterial erectile dysfunction using 320-detector row dynamic volume CT.

Authors:  Cheng-Cheng Xu; Xin-Zhong Ruan; Yi-Fan Tang; Jiao-Hai Pan; Guo-Yao Wang; Qiu-Li Huang
Journal:  Biosci Rep       Date:  2017-08-21       Impact factor: 3.840

6.  The Sentiment Analysis of Tweets as a New Tool to Measure Public Perception of Male Erectile and Ejaculatory Dysfunctions.

Authors:  Andrea Sansone; Angelo Cignarelli; Giacomo Ciocca; Carlotta Pozza; Francesco Giorgino; Francesco Romanelli; Emmanuele A Jannini
Journal:  Sex Med       Date:  2019-08-05       Impact factor: 2.491

Review 7.  Facing Counterfeit Medications in Sexual Medicine. A Systematic Scoping Review on Social Strategies and Technological Solutions.

Authors:  Andrea Sansone; Béatrice Cuzin; Emmanuele A Jannini
Journal:  Sex Med       Date:  2021-10-04       Impact factor: 2.491

8.  Predictive factors of erectile dysfunction in Egyptian individuals after contracting COVID-19: A prospective case-control study.

Authors:  Hany Mohammed Saad; Sameh Fayek GamalEl Din; Osama Mohamed Elbokl; Ahmed Adel
Journal:  Andrologia       Date:  2021-11-13       Impact factor: 2.532

9.  Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men.

Authors:  A Sansone; S Kliesch; M Dugas; R Sandhowe-Klaverkamp; A M Isidori; S Schlatt; M Zitzmann
Journal:  J Endocrinol Invest       Date:  2021-04-03       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.